(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 14.91% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Axogen's revenue in 2025 is $194,521,000.On average, 3 Wall Street analysts forecast AXGN's revenue for 2025 to be $9,855,731,122, with the lowest AXGN revenue forecast at $9,814,741,482, and the highest AXGN revenue forecast at $9,896,720,761. On average, 3 Wall Street analysts forecast AXGN's revenue for 2026 to be $11,577,295,985, with the lowest AXGN revenue forecast at $11,285,814,103, and the highest AXGN revenue forecast at $11,805,016,205.
In 2027, AXGN is forecast to generate $13,483,314,226 in revenue, with the lowest revenue forecast at $13,462,819,406 and the highest revenue forecast at $13,503,809,046.